Taken all, ribosomal dysfunction-responsive PRDM1-IGF signaling contributed to cancer cell stemness and subsequent tumor cell survival from anticancer actions via preferential regulation of non-canonical Wnt-linked pathways (Fig. 9f). The gene discussed is PRDM1; the disease is neoplasm.